Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/23/2003EP1303589A1 Pre-adipose cell lines
04/23/2003EP1303587A2 Synchronised arabidopsis cell suspensions and uses thereof
04/23/2003EP1303586A1 Dna/rna-embedding medium and method of use
04/23/2003EP1303566A1 Superparamagnetic pearl polymers
04/23/2003EP1303540A2 Multi-specific reagent for selective stimulation of cell surface receptors
04/23/2003EP1303539A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
04/23/2003EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use
04/23/2003EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments
04/23/2003EP1303534A2 Promyostatin peptides and methods of using same
04/23/2003EP1303530A2 CLONING AND PRODUCING THE N. i Bst /i NBI NICKING ENDONUCLEASE AND RELATED METHODS FOR USING NICKING ENDONUCLEASES IN SINGLE-STRANDED DISPLACEMENT AMPLIFICATION
04/23/2003EP1303299A1 Compositions and methods for enhancing immunogenicity of antigens
04/23/2003EP1303293A2 Apo-2l receptor agonist and cpt-11 synergism
04/23/2003EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
04/23/2003EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
04/23/2003EP1235842A4 Rna interference pathway genes as tools for targeted genetic interference
04/23/2003EP1212462A4 Methods of determining the presence of double stranded nucleic acids in a sample
04/23/2003EP1190039A4 Gene encoding short integuments and uses thereof
04/23/2003EP1151125A4 Biocatalytic synthesis of quinic acid and conversion to hydroquinone
04/23/2003EP1144685B1 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
04/23/2003EP1141323A4 Mammalian lysophosphatidic acid acyltransferase
04/23/2003EP1123417B1 Method for the exponential amplification of molecular matrices
04/23/2003EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity
04/23/2003EP1098966A4 Methods for purifying nucleic acids
04/23/2003EP1098965A4 Process for conversion of germplasm
04/23/2003EP1057033B1 Treating cancer
04/23/2003EP1057032B1 Treating cancer
04/23/2003EP1057031B1 Treating cancer
04/23/2003EP1057030B1 Treating cancer
04/23/2003EP1057029B1 Treating cancer
04/23/2003EP1057028B1 Treating cancer
04/23/2003EP1040351A4 C-terminal region of agouti-related transcript (art) protein
04/23/2003EP1019503A4 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
04/23/2003EP1018009B1 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material
04/23/2003EP1007558B1 Familial mediterranean fever gene
04/23/2003EP1007532B1 Oligonucleotides for identifying precursors of amidated polypeptide hormones
04/23/2003EP0988394A4 Compositions for the detection of enzyme activity in biological samples and methods of use thereof
04/23/2003EP0961827A4 Mammalian and human rec2
04/23/2003EP0927258B1 System for in vitro transposition using modified tn5 transposase
04/23/2003EP0906571B1 Labelling and selection of molecules
04/23/2003EP0880536B1 Process for preparing purified nucleic acid and the use thereof
04/23/2003EP0871654B1 Protegrins
04/23/2003EP0871642B1 Nucleic acid mediated electron transfer
04/23/2003EP0868530B1 A cascade nucleic acid amplification reaction
04/23/2003EP0857177B1 Process for the preparation of a single chain fv antibody fragment
04/23/2003EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
04/23/2003EP0791008A4 Screen for compounds with affinity for rna
04/23/2003EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody
04/23/2003EP0672145B1 Interleukin-3 (il-3) multiple mutation polypeptides
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
04/23/2003EP0546124B2 Multidomain hematopoiesis stimulators
04/23/2003EP0483249B1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
04/23/2003CN1413300A Chromatography material and method using same
04/23/2003CN1413264A Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators
04/23/2003CN1413263A Oligomer array with PNA and/or DNA oligomers on surface
04/23/2003CN1413262A Detection system for analyzing molecular interactions, production and utilization thereof
04/23/2003CN1413258A Invasive bacterial vectors for expressing alphavirus replicons
04/23/2003CN1413257A Trans-species transfer of apoptotic genes and transgenic plants developed thereby
04/23/2003CN1413256A Modified DHPS genes
04/23/2003CN1413255A Production of transgenic plants of tagetes species
04/23/2003CN1413254A Maize MIP synthase promoter
04/23/2003CN1413253A Phosphatases with improved phytase activity
04/23/2003CN1413252A 新型酶 The new enzyme
04/23/2003CN1413251A Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, DNA encoding this protein and gene remedies containing the same
04/23/2003CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells
04/23/2003CN1413249A Human heparanase-related polypeptide and nucleic acid
04/23/2003CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls
04/23/2003CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use
04/23/2003CN1413219A Molecular structure of RHD negative genes locus
04/23/2003CN1412562A Preparation method of reagent for diagnosing cardiac infarction and its active components
04/23/2003CN1412323A Method for screening transgenic plant and its used bivalent plant expression vector
04/23/2003CN1412314A Virus expression veclor of tomato flower-leaf virus low virulent strain K
04/23/2003CN1412313A Expression of recombinant human troponin I in colibacillus and its application for resisting tumor
04/23/2003CN1412312A Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor
04/23/2003CN1412311A Method for raising microbial pesticide effect by utilizing synergistic action of infection related gene
04/23/2003CN1412310A Enzyme with protease activity
04/23/2003CN1412309A CDNA library of human bronchial epicyte malignant transformation differential expression gene and clone related to lesion of cancer of lung
04/23/2003CN1412308A Synthesis of calcitonin gene according to plant preference codon and its application in plant
04/23/2003CN1412307A Soybean stem apex transformation vacuum permeation helped exogenous gene introduction method
04/23/2003CN1412303A Recombinant gland related virus expressing human kallikrein, its preparation method and application
04/23/2003CN1412299A Ecological safety type nitragin preparation production process and its production method
04/23/2003CN1412295A Oncolytic microorganism expressing heat shock protein and its application
04/23/2003CN1412200A Method for preparing recombinant human bone morphogenetic protein-7 mature peptide dimer
04/23/2003CN1412199A Wheat TaDREB, its code gene and method for culturing adverse-resistant plant
04/23/2003CN1412198A Cell cycle regulatory protein
04/23/2003CN1106447C Human tree protuberant cytoma immuno-therapeutic preparation for oriented proliveration and expression interleukin 12 and its preparation method
04/23/2003CN1106401C 磁性色素 Magnetic pigment
04/23/2003CN1106203C Chlamydia vaccine and process
04/22/2003US6552250 Diacylglycerol O-acyltransferase
04/22/2003US6552248 Transforming plant with target site comprising nucleotide sequence operably linked to promoter, target site is flanked by non-identical recombination sites; locating preferred integration site by selecting plant expressing nucleotide
04/22/2003US6552246 Marker sequence has been substituted for at least intron 6 and exon 6, and wherein disruption prevents expression of CD45 on B-cells and T-cells and results in a decreased cytotoxic T-cell response
04/22/2003US6552199 Fluorescence dyes and their use as fluorescence markers
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6552179 Mutant luciferases
04/22/2003US6552169 Density enhanced protein tyrosine phosphatases
04/22/2003US6552005 Treating with the adenovirus encoding cytosine deaminase gene and uracil phosphoribosyltranserase gene; administering 5-fluorocytosine; therapy with radiation
04/22/2003US6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF
04/22/2003US6551996 Super-active porcine growth hormone releasing hormone analog
04/22/2003US6551991 Recombinant proteins derived from HGF and MSP
04/22/2003US6551989 Preventing airway mucus production by administration of EGF-R antagonists